-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Rocket Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2023.
- Rocket Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$69.6M, a 6% decline year-over-year.
- Rocket Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$253M, a 1.91% decline year-over-year.
- Rocket Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$246M, a 10.7% decline from 2022.
- Rocket Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$222M, a 31.2% decline from 2021.
- Rocket Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$169M, a 21% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)